Meyer-Almes Franz-Josef
Department of Chemical Engineering and Biotechnology, University of Applied Sciences, Schnittspahnstr. 12, 64287, Darmstadt, Germany.
Eur Biophys J. 2016 Apr;45(3):245-57. doi: 10.1007/s00249-015-1090-1. Epub 2015 Nov 4.
Molecular recognition between proteins and small molecule ligands is at the heart of biological function in cellular systems and the basis of modern rational drug development. Therefore, the mechanisms governing protein-ligand interaction have been objects of research for many decades. The last 15 years has seen a revival of a discussion whether conformational selection (CS) or induced fit (IF) is the most relevant binding mechanism. A decreasing observed rate constant, k obs, with increasing ligand concentration was considered to be a hallmark of CS, but according to contemporary knowledge, a positive saturating behavior of k obs can be explained by both CS and IF mechanisms. The only currently recognized kinetic method to differentiate between both binding mechanisms includes the measurement of two separate series of binding kinetics with variation of either protein or ligand under pseudo-first-order conditions. This study avoids the disadvantage of high protein concentrations and provides evidence that a comprehensive Integrated Global Fit analysis of sets of binding kinetics with just varied ligand concentration in combination with equilibrium data and optional displacement kinetics can effectively differentiate between CS and IF binding mechanisms. The limiting situation, when physical binding dominates over the previous (CS) or subsequent (IF) conformational changes, is carefully analyzed. Finally, the relevance of kinetic methods and the elucidation of more complex binding mechanisms are discussed for advanced rational selection and optimization of drug candidates.
蛋白质与小分子配体之间的分子识别是细胞系统生物学功能的核心,也是现代合理药物开发的基础。因此,几十年来,调控蛋白质-配体相互作用的机制一直是研究对象。在过去15年里,关于构象选择(CS)或诱导契合(IF)哪种是最相关的结合机制的讨论再度兴起。随着配体浓度增加,观察到的速率常数kobs降低被认为是CS的一个标志,但根据当代知识,kobs的正饱和行为可以用CS和IF机制来解释。目前唯一公认的区分这两种结合机制的动力学方法包括在准一级条件下,通过改变蛋白质或配体来测量两个独立的结合动力学系列。本研究避免了高蛋白质浓度的缺点,并提供证据表明,仅通过改变配体浓度,并结合平衡数据和可选的置换动力学,对结合动力学集进行全面的综合全局拟合分析,能够有效区分CS和IF结合机制。我们仔细分析了物理结合比先前(CS)或后续(IF)构象变化占主导的极限情况。最后,讨论了动力学方法的相关性以及阐明更复杂结合机制对于高级合理选择和优化候选药物的意义。